Screening for Colorectal Cancer Kemal I Deen MS MD FRCS
Kurunegala Clinical Society- 2015
Worldwide West • Colorectal cancer (CRC) is the 2nd most common cancer in women • In men, CRC is the 3rd most common cancer • Overall, CRC is the 4th most common cause of cancer related deaths Sri Lanka 4th most common cancer in 2013 – Globocan
CRC- Potentially totally preventable
• Breast – Screening is aimed at detecting the early cancer • CRC – Screening is aimed at detecting the polyp
Breast vs. Colorectal
Totally preventable?
Almost all CRC develops from a pre-existing, slow growing polyp (adenoma) that is the pre-malignant state of CRC.
The origin of an adenoma Shed off by programmed cell death
Life span of 3 to 5 days
Survives on the epithelial surface using fatty acids derived from luminal bacterial action of fibre
Regulate upward movement of colonocyte
Intestinal stem cells
The origin of an adenoma
The origin of an adenoma
Adenoma to dysplasia to carcinoma Polyp – Dysplasia - Cancer 5 Years
APC Chr 5
K ras Chr 12
DCC Chr 18
p 53 Chr 17
What’s the evidence for screening? • Colonoscopic polypectomy and long-term prevention of colorectalcancer deaths. • Zauber AG1, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD. NEJM -2012
53% Reduction in mortality
Effect on CRC incidence in a screened population SEER 9 Incidence & U.S. Mortality 1975-2012, All Races, Both Sexes. Rates are Age-Adjusted.
Year
1975
1980
1985
1990
1995
1999
2003
2007
5-Year Relative Survival
48.6 %
51.1 %
58.0 %
60.8 %
59.7 %
64.5 %
65.3 %
66.5 %
The Aim
Classification of Colorectal Cancer
CRC SPORADIC CANCER
FAMILIAL CANCER
Middle aged / Elderly
Familial Adenomatous Polyposis
Young age <40
Hereditary non-polyposis CRC One 1st degree relative with CRC
Colorectal Cancer Risk • High risk
FAP family members; Longstanding ulcerative colitis Crohn’s Colitis; HNPCC.
• Moderate risk
Previous CRC; >1cm Villous adenoma
• Average risk
Any person >50 (White Caucasian) or >40 South Asian
Principles 1. To establish a colon free of polyps – “Clean Colon” in individuals who reach the “at-risk” age
White Caucasian – 50 years Sri Lankan- 40 Years Familial Adenomatous Polyposis – 12 years Hereditary non-polyposis cancer – 5years before the youngest family member 2. To ensure a colon free of polyps or a colon with an endoscopically treatable polyp during the remainder of an individual’s lifespan
How do we achieve? Establishment of a “clean colon” Total colonoscopy CT- Colonography Flexible sigmoidoscopy + Faecal occult blood tests
Establishing a polyp-free colon in the future Colonoscopy at regular intervals – Average risk – Moderate risk – High risk -
once per 5 - 10 years once per 2 to 5 years once per 3months to 2years
Establishing a polyp-free colon in the future Alternative Faecal occult blood x 3 consecutive days – every 2 years, with flexible sigmoidoscopy every 3 to 5 years
Colonoscopy if faecal occult blood test is positive
When to stop?
Between age 75 to 79 years > 80 – Screening should be considered on an individual basis
Conclusion Colonoscopic screening is recommended in all current guidelines at 10-year intervals in the average-risk population at 5 to 10-year intervals among patients with 1 or 2 small (<10 mm) tubular adenomas, at 5-year intervals when there is a history of advanced adenomas on previous colonoscopies, and at 3-year-intervals for patients with>3 small adenomas, an adenoma with villous features or highgrade dysplasia, or an adenoma>1 cm in size. Systematic overuse of colonoscopy for screening and polyp surveillance must be avoided – it is not cost effective and it exposes patients to excess risk, and its systematic performance cannot be justified.
Screening for Colorectal Cancer - Kurunegala Clinical Society
Establishing a polyp-free colon in the future. Colonoscopy at regular intervals â. Average risk â once per 5 - 10 years. Moderate risk â once per 2 to 5 years. High risk - once per 3months to 2years ...
CRC- Potentially totally preventable. â¢Breast â Screening is aimed at detecting the early cancer. â¢CRC â Screening is aimed at detecting the polyp ...
... carried out by the National Cancer Institute, called the Health Information ... Affordable Care Act, all Marketplace plans and many other plans must cover ...
But several screening tests can also help find abnormal cells that have not yet ... more about colorectal cancer, visit the National Cancer Institute (NCI) website at.
Dec 17, 2009 - serve University School of Medicine and ... quired for repair of baseâbase mismatches in DNA, collectively referred to as mis-. The New ...... ic mutations in simple repeated sequences reveal a new mechanism for colonic car-.
Analysis 01.01. Comparison 01 Screening vs control, Outcome 01 Prostate cancer specific mortality ... This version first published online: 19 July 2006 in Issue 3, 2006. ... controlled trials were identified as meeting the review's inclusion criteria
Dec 17, 2009 - From the Department of Medicine and. Ireland Cancer Center, Case Western Re- serve University School of Medicine and. Case Medical Center, Cleveland (S.D.M.); the Howard Hughes Medical Institute,. Chevy Chase, MD (S.D.M.); and Brigham
solutions designed to eliminate cancer as a major ...... suffering and maintain the best possible quality of life for patients and .... wordpress.com/2016/01/8806-the-burden-of-medical- ... February 22, 2017. https://www.acscan.org/sites/default/.
Cancer is one of the leading causes of death and disease in the. U.S. The American ... Total U.S. Expenditures for Cancer by Type of Serviceâ2014. Medicaid.
The American Society of Colon and Rectal Surgeons. (ASCRS) is dedicated to assuring high-quality pa- tient care by advancing the science, prevention,. and management of disorders and diseases of the colon,. rectum, and anus. The Clinical Practice Gui
provided little support for the effectiveness of âtreatment as usualâ in this setting (overall effect size of -.08), .... A continuum of care: More is not always better.
Newborn Screening (NBS) involves a series of laboratory and medical tests performed mainly ... and Reference Laboratory for the state's NBS Program. Every year ..... Annals of Clinical Laboratory Science 23(6): 433-438, 1993. 12. Aguinaga ...
There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. Kurunegala(E).
Try one of the apps below to open or edit this item. pdf-1897\american-cancer-society-complete-guide-to-complementary-alternative-cancer-therapies.pdf.
Oct 14, 2016 - University of Iowa College of Law. ... Tucson, Arizona; Los Angeles and Orange County, California; Denver, Colorado; Las Vegas and Reno,.